Search results
Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease
Pharmaceutical Technology· 1 day agoEisai and Biogen must now brace for competition as the US Food and Drug Administration (FDA) has...
Eli Lilly inks another radiopharma deal, gaining option to buy startup
BioPharma Dive· 2 days agoDive Brief: Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics...
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 23 hours agoA sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. The U.S. Food and Drug Administration on Tuesday,...
USFDA approves second Alzheimer's drug that can modestly slow disease
Business Standard India· 22 hours agoThe Food and Drug Administration approved Eli Lilly's Kisunla on Tuesday for mild or early cases of...
Govt panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Business Standard India· 2 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 2 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro - ET HealthWorld | Pharma
The Economic Times· 2 days agoHyderabad: An Indian government-approved expert panel has advised the country's drug regulator to...
Blockbuster diabetes & obesity drug gets nod for India launch but may be available only next year
Theprint· 1 day ago“The company now has the regulatory approval in place to launch the drug in India but we can do that in about six months from now after assessing the drug’s global supply chain status,” a source ...
Novo Nordisk must cut prices of weight-loss drug, Biden says in USA Today piece - ET HealthWorld |...
The Economic Times· 1 day agoWeight-loss Drug Price Cut: Biden and Sanders also said Eli Lilly was charging high prices for its...
The Tide Begins to Turn Against Biden
The Dispatch· 12 hours agoThe Food and Drug Administration on Tuesday approved a drug—donanemab, sold under the name Kisunla and produced by Eli Lilly—that could slightly slow...
